11.2.2019
EN
Official Journal of the European Union
C 54/31
Action brought on 14 December 2018 — Dalasa v EUIPO — Charité — Universitätsmedizin Berlin (charantea)
(Case T-732/18)
(2019/C 54/46)
Language in which the application was lodged: German
Parties
Applicant: Dalasa Handelsgesellschaft mbH (Vienna, Austria) (represented by: I. Hödl, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Charité — Universitätsmedizin Berlin, Gliedkörperschaft Öffentlichen Rechts (Berlin, Germany)
Details of the proceedings before EUIPO
Applicant for the mark at issue: Applicant
Mark at issue: Application for EU word mark charantea — Application for registration No 15 485 956
Proceedings before EUIPO: Opposition proceedings
Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 15 October 2018 in Case R 539/2018-4
Form of order sought
The applicant claims that the Court should:
—
uphold the action, alter the contested decision of the Fourth Board of Appeal of 15 October 2018, R 539/2018-4 concerning opposition proceedings B 2 758 830 (EU trade mark application No 15 485 956), reject the opposition, and allow the EU trade mark application to proceed to registration;
in the alternative,
—
annul the contested decision of the Fourth Board of Appeal of 15 October 2018, R 539/2018-4 concerning opposition proceedings B 2 758 830 (EU trade mark application No 15 485 956) and refer the case back to EUIPO;
—
in any event, order EUIPO to pay the costs of the present proceedings; and
—
order the opposing party to pay all of the costs incurred in the proceedings before the Opposition Division and the Board of Appeal.
Plea in law
—
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.